{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:03:19Z","timestamp":1787317399478,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2021T055"],"award-info":[{"award-number":["2021T055"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1106154"],"award-info":[{"award-number":["APP1106154"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1142938"],"award-info":[{"award-number":["APP1142938"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["2017T039"],"award-info":[{"award-number":["2017T039"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003092","name":"Diabetes Fonds","doi-asserted-by":"publisher","award":["2017.85.005"],"award-info":[{"award-number":["2017.85.005"]}],"id":[{"id":"10.13039\/501100003092","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.biopha.2022.114211","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T12:41:49Z","timestamp":1672749709000},"page":"114211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Pyridoxamine prevents increased atherosclerosis by intermittent methylglyoxal spikes in the aortic arches of ApoE-\/- mice"],"prefix":"10.1016","volume":"158","author":[{"given":"Nordin M.J.","family":"Hanssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Tikellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raelene J.","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Dragoljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man Kit Sam","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean LJM","family":"Scheijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiaan","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merlin C.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper G.","family":"Schalkwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.114211_bib1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1056\/NEJMc1706292","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"377","author":"Rawshani","year":"2017","journal-title":"New Engl. J. Med"},{"key":"10.1016\/j.biopha.2022.114211_bib2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1172\/JCI117296","article-title":"Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes","volume":"94","author":"Giardino","year":"1994","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2022.114211_bib3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.114211_bib4","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00125-015-3597-5","article-title":"Vascular AGE-ing by methylglyoxal: the past, the present and the future","volume":"58","author":"Schalkwijk","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2022.114211_bib5","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/eurheartj\/eht402","article-title":"Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype","volume":"35","author":"Hanssen","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2022.114211_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004502","article-title":"Integrative genomics reveals novel molecular pathways and gene networks for coronary artery disease","volume":"10","author":"Makinen","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1016\/j.biopha.2022.114211_bib7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nm.4328","article-title":"Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction","volume":"23","author":"Qi","year":"2017","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2022.114211_bib8","doi-asserted-by":"crossref","DOI":"10.2337\/db13-0932","article-title":"Dicarbonyl stress in the absence of hyperglycemia increases endothelial inflammation and atherogenesis similar to that observed in diabetes","author":"Tikellis","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.114211_bib9","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.2337\/db16-1578","article-title":"Higher plasma methylglyoxal levels are associated with incident cardiovascular disease in individuals with type 1 diabetes: a 12-year follow-up study","volume":"66","author":"Hanssen","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.114211_bib10","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2337\/dc18-0159","article-title":"Higher plasma methylglyoxal levels are associated with incident cardiovascular disease and mortality in individuals with type 2 diabetes","volume":"41","author":"Hanssen","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.114211_bib11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2337\/dc14-2605","article-title":"Post-glucose load plasma alpha-dicarbonyl concentrations are increased in individuals with impaired glucose metabolism and type 2 diabetes: The CODAM Study","volume":"38","author":"Maessen","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.114211_bib12","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00125-016-4009-1","article-title":"Energy restriction and Roux-en-Y gastric bypass reduce postprandial alpha-dicarbonyl stress in obese women with type 2 diabetes","volume":"59","author":"Maessen","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2022.114211_bib13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jama.2016.19975","article-title":"Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the diamond randomized clinical trial","volume":"317","author":"Beck","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2022.114211_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(18)30290-3","article-title":"Continuous glucose monitoring: transforming diabetes management step by step","author":"Bergenstal","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.114211_bib15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1159\/000108104","article-title":"Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy","volume":"27","author":"Williams","year":"2007","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.biopha.2022.114211_bib16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00125-010-2000-9","article-title":"Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice","volume":"54","author":"Watson","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2022.114211_bib17","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/db15-1390","article-title":"Delayed intervention with pyridoxamine improves metabolic function and prevents adipose tissue inflammation and insulin resistance in high-fat diet-induced obese mice","volume":"65","author":"Maessen","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2022.114211_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1681\/ASN.2011111097","article-title":"Pyridoxamine, advanced glycation inhibition, and diabetic nephropathy","volume":"23","author":"Chen","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.114211_bib19","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/nprot.2014.129","article-title":"Measurement of methylglyoxal by stable isotopic dilution analysis LC-MS\/MS with corroborative prediction in physiological samples","volume":"9","author":"Rabbani","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2022.114211_bib20","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1093\/eurheartj\/ehy119","article-title":"Defective cholesterol metabolism in haematopoietic stem cells promotes monocyte-driven atherosclerosis in rheumatoid arthritis","volume":"39","author":"Dragoljevic","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2022.114211_bib21","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cmet.2014.03.029","article-title":"Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity","volume":"19","author":"Nagareddy","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2022.114211_bib22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.cmet.2013.04.001","article-title":"Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis","volume":"17","author":"Nagareddy","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2022.114211_bib23","first-page":"1","article-title":"Quantification of glyoxal, methylglyoxal and 3-deoxyglucosone in blood and plasma by ultra performance liquid chromatography tandem mass spectrometry: evaluation of blood specimen","author":"Scheijen","year":"2013","journal-title":"Clin. Chem. Lab Med"},{"key":"10.1016\/j.biopha.2022.114211_bib24","doi-asserted-by":"crossref","first-page":"E1369","DOI":"10.1210\/jc.2013-1068","volume":"98","author":"Hanssen","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2022.114211_bib25","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cmet.2021.05.005","article-title":"Fecal microbiota transplantation in human metabolic diseases: from a murky past to a bright future?","volume":"33","author":"Hanssen","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2022.114211_bib26","doi-asserted-by":"crossref","first-page":"9879","DOI":"10.1038\/s41598-017-10663-w","article-title":"Unveiling the gut microbiota composition and functionality associated with constipation through metagenomic analyses","volume":"7","author":"Mancabelli","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.114211_bib27","article-title":"Fasting and post-oral-glucose-load levels of methylglyoxal are associated with microvascular, but not macrovascular, disease in individuals with and without (pre)diabetes: The Maastricht Study","author":"Hanssen","year":"2020","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.biopha.2022.114211_bib28","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/CIRCRESAHA.120.316653","article-title":"Transient intermittent hyperglycemia accelerates atherosclerosis by promoting myelopoiesis","volume":"127","author":"Flynn","year":"2020","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2022.114211_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1681\/ASN.2011030272","article-title":"Collaborative Study G: pyridorin in type 2 diabetic nephropathy","volume":"23","author":"Lewis","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.114211_bib30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41586-018-0622-0","article-title":"A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling","volume":"562","author":"Bollong","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.114211_bib31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s00125-013-3088-5","article-title":"Glyoxalase-1 overexpression reduces endothelial dysfunction and attenuates early renal impairment in a rat model of diabetes","volume":"57","author":"Brouwers","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2022.114211_bib32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/cvr\/cvu189","article-title":"Glyoxalase 1 overexpression does not affect atherosclerotic lesion size and severity in ApoE-\/- mice with or without diabetes","volume":"104","author":"Hanssen","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.biopha.2022.114211_bib33","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12043","article-title":"Differential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice","volume":"2","author":"Geoffrion","year":"2014","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.biopha.2022.114211_bib34","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1196\/annals.1333.093","article-title":"Pyridoxamine: the many virtues of a maillard reaction inhibitor","volume":"1043","author":"Voziyan","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222016006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222016006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T11:24:13Z","timestamp":1779794653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222016006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":34,"alternative-id":["S0753332222016006"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.114211","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyridoxamine prevents increased atherosclerosis by intermittent methylglyoxal spikes in the aortic arches of ApoE-\/- mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.114211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114211"}}